Medium materiality6/10
Guardant Health price target raised to $150 from $120 at Barclays
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS raises GH target to $150; current price $130.83.
- UBS raises Guardant Health target to $150; price $130.83.
Key facts
- 01
Target: $150
- 02
Posted price: $130.83
- 03
Analyst firm: UBS
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.